Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Houston

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Cancer Research|June 1, 1990
Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cellsY H Yu, J R Crews, K Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptideA J George, F Jamar, M S Tai, et al.
Cancer Research|September 1, 1993
Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain FvG P Adams, J E McCartney, M S Tai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Enhanced tumor specificity of 741F8-1 (sFv')2, an anti-c-erbB-2 single-chain Fv dimer, mediated by stable radioiodine conjugationG P Adams, J E McCartney, E J Wolf, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administrationG P Adams, J E McCartney, E J Wolf, et al.
Neurosurgery|November 15, 1997
Intraventricular immunotoxin therapy for leptomeningeal neoplasiaD W Laske, K M Muraszko, E H Oldfield, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1996
Single-chain Fv radioimmunotargetingJ S Huston, A J George, G P Adams, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Cancer Research|June 1, 1990
Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cellsY H Yu, J R Crews, K Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 1995
Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptideA J George, F Jamar, M S Tai, et al.
Cancer Research|September 1, 1993
Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain FvG P Adams, J E McCartney, M S Tai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1995
Enhanced tumor specificity of 741F8-1 (sFv')2, an anti-c-erbB-2 single-chain Fv dimer, mediated by stable radioiodine conjugationG P Adams, J E McCartney, E J Wolf, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administrationG P Adams, J E McCartney, E J Wolf, et al.
Neurosurgery|November 15, 1997
Intraventricular immunotoxin therapy for leptomeningeal neoplasiaD W Laske, K M Muraszko, E H Oldfield, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1996
Single-chain Fv radioimmunotargetingJ S Huston, A J George, G P Adams, et al.
Pageof 10